Phlorizin

Phlorizin is a dihydrochalcone glucoside found in apple tree bark that functions as a sodium-glucose linked transporter (SGLT) inhibitor. This compound blocks glucose reabsorption in the kidneys, leading to glucose excretion and potential blood sugar management effects.

Origin & History

Phlorizin is a naturally occurring dihydrochalcone glucoside primarily extracted from apple tree bark, leaves, seeds, and roots, particularly from unripe apples (Malus species). It is chemically designated as a polyphenolic flavonoid with molecular formula C₂₁H₂₄O₁₀ and is typically extracted using ethanol or hot water extraction methods.

Historical & Cultural Context

Traditional use information is not documented in the available research. Historical applications in traditional medicine systems such as Ayurveda or Traditional Chinese Medicine are not specified in current sources.

Health Benefits

• May support blood sugar regulation through SGLT inhibition (preliminary evidence only)
• Potentially improves memory function (mechanism unverified, preliminary evidence)
• May induce experimental glucosuria for glucose management (animal studies only)
• Possible anti-allergy properties (evidence quality not established)
• Reported anticancer potential (no clinical trials available)

How It Works

Phlorizin competitively inhibits sodium-glucose linked transporters (SGLT1 and SGLT2) in the kidneys and intestines, preventing glucose reabsorption and promoting glucose excretion through urine. The compound also appears to modulate glucose metabolism in the brain, potentially affecting memory formation through improved neuronal glucose utilization. Additional mechanisms may involve inhibition of glucose absorption in the small intestine via SGLT1 blockade.

Scientific Research

The available research lacks peer-reviewed clinical trials, RCTs, or meta-analyses with PMIDs. Current evidence is limited to preliminary reports of biological activities without validated human studies or documented clinical outcomes.

Clinical Summary

Current evidence for phlorizin comes primarily from animal studies and preliminary human research. Animal studies demonstrate significant glucose-lowering effects through induced glucosuria, with some rodent models showing 20-30% reductions in blood glucose levels. Memory enhancement studies are limited to animal models, showing improved cognitive performance in maze tests. Human clinical trials are scarce, with most evidence remaining at the preclinical stage, limiting conclusions about therapeutic efficacy and optimal dosing.

Nutritional Profile

Phlorizin is a purified dihydrochalcone flavonoid compound (C21H24O10), not a whole food or dietary supplement in the traditional sense, and therefore has no conventional macronutrient or micronutrient profile. Molecular weight: 436.41 g/mol. It is a glycoside consisting of phloretin (aglycone) bound to glucose via a beta-glycosidic bond. Naturally occurring concentrations in food sources: apple tree bark (up to 1-5% dry weight), apple roots (highest concentrations, ~2-4 g/kg dry weight), apple leaves (~0.5-2 g/kg dry weight), and apple fruit skin (trace amounts, ~0.5-1 mg/kg fresh weight). Also found in smaller quantities in pear and cherry tree bark. As an isolated compound, it contains no protein, fat, fiber, or micronutrients. Bioactive profile centers entirely on its SGLT1 and SGLT2 inhibitory activity, with an IC50 of approximately 0.3-1 µM for SGLT2 inhibition. Bioavailability when ingested is limited due to hydrolysis by intestinal lactase-phlorizin hydrolase (LPH), which cleaves it into phloretin and glucose before absorption; phloretin itself is then absorbed with moderate bioavailability (~20-30% estimated). It is primarily a research compound and not present in meaningful dietary quantities through normal food consumption.

Preparation & Dosage

No clinically studied dosage ranges are available in the current research. Standardization protocols and dosing recommendations for different formulations have not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Catechin, Epicatechin, Procyanidins, Rutin

Safety & Interactions

Phlorizin may cause excessive glucose loss through urine, potentially leading to dehydration or electrolyte imbalances in sensitive individuals. The compound could theoretically interact with diabetes medications, particularly SGLT2 inhibitors like empagliflozin, potentially causing additive glucose-lowering effects. Pregnant and breastfeeding women should avoid phlorizin supplementation due to lack of safety data. Individuals with kidney disease should exercise caution as the compound affects renal glucose handling.